Andrew Wilks
Fondatore presso SYN thesis med chem Pty Ltd.
Posizioni attive di Andrew Wilks
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Medicines Development for Global Health Ltd
 Medicines Development for Global Health Ltd Pharmaceuticals: MajorHealth Technology Medicines Development Ltd. engages in the development of medicines and vaccines. Its development programs include Moxidectin Program, Global Health Programs, and Consulting ervices. The company was founded by Mark Sullivan in 2005 and is headquartered in Melbourne, Australia. | Direttore/Membro del Consiglio | - | - |
SYN thesis med chem Pty Ltd.
 SYN thesis med chem Pty Ltd. BiotechnologyHealth Technology SYN thesis med chem Pty Ltd. engages in the development and provision of molecule drug discovery services. It offers integrated drug discovery, medicinal and synthetic chemistry, single compound synthesis, and catalogue products. The company was founded by Andrew Wilks and Xian Bu and is headquartered in Parkville, Australia. | Presidente | - | - |
| Fondatore | - | - | |
Chuangsheng Qiao Kang Pharmaceutical Co., Ltd.
 Chuangsheng Qiao Kang Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Chuangsheng Qiao Kang Pharmaceutical Co., Ltd. develops ocular therapeutics and treatments for rare diseases. The private company is based in Beijing, CN. and has subsidiaries in the United States. The CEO of the Chinese company is Darren Mercer. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Andrew Wilks
Statistiche
Distribuzione geografica
| Australia | 3 |
| Cina | 2 |
Posizioni
| Director/Board Member | 2 |
| Chairman | 1 |
| Founder | 1 |
Settori
| Health Technology | 3 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 3 |
|---|---|
Medicines Development for Global Health Ltd
Medicines Development for Global Health Ltd Pharmaceuticals: MajorHealth Technology Medicines Development Ltd. engages in the development of medicines and vaccines. Its development programs include Moxidectin Program, Global Health Programs, and Consulting ervices. The company was founded by Mark Sullivan in 2005 and is headquartered in Melbourne, Australia. | Health Technology |
SYN thesis med chem Pty Ltd.
SYN thesis med chem Pty Ltd. BiotechnologyHealth Technology SYN thesis med chem Pty Ltd. engages in the development and provision of molecule drug discovery services. It offers integrated drug discovery, medicinal and synthetic chemistry, single compound synthesis, and catalogue products. The company was founded by Andrew Wilks and Xian Bu and is headquartered in Parkville, Australia. | Health Technology |
Chuangsheng Qiao Kang Pharmaceutical Co., Ltd.
Chuangsheng Qiao Kang Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Chuangsheng Qiao Kang Pharmaceutical Co., Ltd. develops ocular therapeutics and treatments for rare diseases. The private company is based in Beijing, CN. and has subsidiaries in the United States. The CEO of the Chinese company is Darren Mercer. | Commercial Services |
- Borsa valori
- Insiders
- Andrew Wilks
- Esperienza
